Delay In OTC Loratadine Coverage By Medicaid Caused “Lost Savings” – Study
This article was originally published in The Tan Sheet
Executive Summary
A state Medicaid program's failure to cover OTC Claritin (loratadine) immediately after its switch approval was a detriment to potential savings, a study evaluating the cost impact of OTC coverage concludes